Males | Females | p-value | ||
---|---|---|---|---|
Total lesions | 336 | 114 | ||
Bone marrow edema | 200 (60%) | 52 (46%) | 0.0097 | |
Affected vertebral levels | 0.021 | |||
L1 | 1 (0.30%) | 0 (0%) | ||
L2 | 5 (1.49%) | 0 (0%) | ||
L3 | 15 (4.46%) | 17 (15%) | ||
L4 | 52 (15.48%) | 20 (18%) | ||
L5 | 263 (78.27%) | 77 (68%) | ||
Pathological stage | 0.67 | |||
Pre-lysis | 47 (14%) | 16 (14%) | ||
Early | 101 (30%) | 24 (21%) | ||
Progressive | 52 (15%) | 12 (11%) | ||
Bone union | 145 (73%) | 40 (77%) | 0.52 | |
(n = 200) | (n = 52) | |||
Treatment period, median (IQR) | 96 (66–129) | 91.5 (71.5–111) | 0.18 | |
(n = 145) | (n = 40) |